JP2014532754A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532754A5
JP2014532754A5 JP2014540612A JP2014540612A JP2014532754A5 JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5 JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014540612 A JP2014540612 A JP 2014540612A JP 2014532754 A5 JP2014532754 A5 JP 2014532754A5
Authority
JP
Japan
Prior art keywords
oxo
dihydro
compound
ylmethyl
oxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532754A (ja
JP6030146B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/056236 external-priority patent/WO2013068948A1/en
Publication of JP2014532754A publication Critical patent/JP2014532754A/ja
Publication of JP2014532754A5 publication Critical patent/JP2014532754A5/ja
Application granted granted Critical
Publication of JP6030146B2 publication Critical patent/JP6030146B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540612A 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体 Expired - Fee Related JP6030146B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2011/054968 2011-11-08
IB2011054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (3)

Publication Number Publication Date
JP2014532754A JP2014532754A (ja) 2014-12-08
JP2014532754A5 true JP2014532754A5 (cg-RX-API-DMAC10.html) 2015-12-03
JP6030146B2 JP6030146B2 (ja) 2016-11-24

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014540612A Expired - Fee Related JP6030146B2 (ja) 2011-11-08 2012-11-07 2−オキソ−オキサゾリジン−3,5−ジイル抗生物質誘導体

Country Status (21)

Country Link
US (1) US9079922B2 (cg-RX-API-DMAC10.html)
EP (1) EP2776431B1 (cg-RX-API-DMAC10.html)
JP (1) JP6030146B2 (cg-RX-API-DMAC10.html)
KR (1) KR20140096337A (cg-RX-API-DMAC10.html)
AR (1) AR088691A1 (cg-RX-API-DMAC10.html)
AU (1) AU2012335207B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014011064A8 (cg-RX-API-DMAC10.html)
CA (1) CA2854264A1 (cg-RX-API-DMAC10.html)
CL (1) CL2014001154A1 (cg-RX-API-DMAC10.html)
ES (1) ES2581056T3 (cg-RX-API-DMAC10.html)
HK (1) HK1202288A1 (cg-RX-API-DMAC10.html)
IL (1) IL232463A0 (cg-RX-API-DMAC10.html)
IN (1) IN2014CN04126A (cg-RX-API-DMAC10.html)
MX (1) MX344529B (cg-RX-API-DMAC10.html)
PH (1) PH12014500831A1 (cg-RX-API-DMAC10.html)
PL (1) PL2776431T3 (cg-RX-API-DMAC10.html)
RU (1) RU2616609C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201401710PA (cg-RX-API-DMAC10.html)
TW (1) TWI594996B (cg-RX-API-DMAC10.html)
WO (1) WO2013068948A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201404176B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
PL2986607T3 (pl) 2013-04-16 2017-11-30 Idorsia Pharmaceuticals Ltd Przeciwbakteryjne pochodne biaromatyczne
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
MA41169A (fr) 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
US10487093B2 (en) 2016-02-08 2019-11-26 Redx Pharma Plc Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
CA3012569A1 (en) * 2016-02-08 2017-08-17 Redx Pharma Plc Antibacterial compounds
EA201892815A1 (ru) 2016-06-08 2019-05-31 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Новые антибактериальные соединения
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
DK3634968T3 (da) * 2017-06-08 2023-05-01 Bugworks Res Inc Heterocykliske forbindelser, der kan anvendes som antibakterielle midler, og fremgangsmåde til fremstilling heraf
ES2952989T3 (es) * 2017-11-29 2023-11-07 Bugworks Res Inc Compuestos heterocíclicos antibacterianos y su síntesis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
CA1006521A (en) 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
DK164287A (da) 1986-03-31 1987-10-01 Sankyo Co Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な1,8−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
WO2004002973A1 (ja) 2002-06-28 2004-01-08 Kaneka Corporation 光学活性1−置換アミノー2,3−エポキシプロパンの製造方法並びにその合成中間体およびそれらの製造方法
DE602004014361D1 (de) * 2003-04-30 2008-07-24 Morphochem Ag Komb Chemie Verwendung von oxazolidinon-chinolin-hybrid-antibiotika zur behandlung von anthrax und anderen infektionen
JP2007516263A (ja) * 2003-12-18 2007-06-21 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー オキサゾリジノン−キノロンハイブリッド抗生物質
JP2008508243A (ja) * 2004-07-30 2008-03-21 パルメド・ソシエテ・アノニム アミノキノリンをqとし、抗生物質残基をaとする混成分子qa、その合成及び抗菌剤としての使用
CA2578081A1 (en) 2004-09-01 2006-03-09 Ubitrak Inc. System for gaming chip identification and counting
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
PL2086968T3 (pl) * 2006-11-10 2012-07-31 Actelion Pharmaceuticals Ltd Pochodne 5-hydroksymetylooksazolidyn-2-onu
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
ES2380398T3 (es) * 2007-12-18 2012-05-11 Actelion Pharmaceuticals Ltd. Derivados 5-aminociclilmetil-oxazolidin-2-ona
WO2009104159A1 (en) * 2008-02-22 2009-08-27 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
CN104151316B (zh) 2008-10-07 2016-06-15 埃科特莱茵药品有限公司 三环噁唑烷酮抗生素化合物
CA2738775A1 (en) * 2008-10-10 2010-04-15 Actelion Pharmaceuticals Ltd 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents
KR101667066B1 (ko) * 2008-10-10 2016-10-17 액테리온 파마슈티칼 리미티드 옥사졸리디닐 항생제
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2014532754A5 (cg-RX-API-DMAC10.html)
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
RU2501799C2 (ru) Поизводные оксазолидинона
JP2014526500A5 (cg-RX-API-DMAC10.html)
JP2005525324A5 (cg-RX-API-DMAC10.html)
JP2016512558A5 (cg-RX-API-DMAC10.html)
JP2014513110A5 (cg-RX-API-DMAC10.html)
JP2009534386A5 (cg-RX-API-DMAC10.html)
JP2017515844A5 (cg-RX-API-DMAC10.html)
JP2016512511A5 (cg-RX-API-DMAC10.html)
JP2013545798A5 (cg-RX-API-DMAC10.html)
JP2015516000A5 (cg-RX-API-DMAC10.html)
JP2014525432A5 (cg-RX-API-DMAC10.html)
JP2014513139A5 (cg-RX-API-DMAC10.html)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
JP2017504611A5 (cg-RX-API-DMAC10.html)
JP2015514808A5 (cg-RX-API-DMAC10.html)
JP2009532464A5 (cg-RX-API-DMAC10.html)
JP2010265321A5 (cg-RX-API-DMAC10.html)
JP2010132677A5 (cg-RX-API-DMAC10.html)
JP2010510999A5 (cg-RX-API-DMAC10.html)
JP2016511262A5 (cg-RX-API-DMAC10.html)
JP2020512337A5 (cg-RX-API-DMAC10.html)
JP2012515788A5 (cg-RX-API-DMAC10.html)
JP2020529998A5 (cg-RX-API-DMAC10.html)